These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 34935436)
41. Distinct New York City Kaczmarek ME; Herzog NL; Noval MG; Zuzworsky J; Shah Z; Bajwa WI; Stapleford KA Viruses; 2020 Jun; 12(7):. PubMed ID: 32605312 [TBL] [Abstract][Full Text] [Related]
42. Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation. Cook LE; Locke MC; Young AR; Monte K; Hedberg ML; Shimak RM; Sheehan KCF; Veis DJ; Diamond MS; Lenschow DJ J Virol; 2019 Dec; 94(1):. PubMed ID: 31619554 [TBL] [Abstract][Full Text] [Related]
43. Proteomic profiling of chikungunya virus-infected human muscle cells: reveal the role of cytoskeleton network in CHIKV replication. Issac TH; Tan EL; Chu JJ J Proteomics; 2014 Aug; 108():445-64. PubMed ID: 24933005 [TBL] [Abstract][Full Text] [Related]
44. Mutations at the Alphavirus E1'-E2 Interdimer Interface Have Host-Specific Phenotypes. Ren SC; Qazi SA; Towell B; Wang JC; Mukhopadhyay S J Virol; 2022 Mar; 96(5):e0214921. PubMed ID: 35019719 [TBL] [Abstract][Full Text] [Related]
45. Caribbean and La Réunion Chikungunya Virus Isolates Differ in Their Capacity To Induce Proinflammatory Th1 and NK Cell Responses and Acute Joint Pathology. Teo TH; Her Z; Tan JJ; Lum FM; Lee WW; Chan YH; Ong RY; Kam YW; Leparc-Goffart I; Gallian P; Rénia L; de Lamballerie X; Ng LF J Virol; 2015 Aug; 89(15):7955-69. PubMed ID: 25995257 [TBL] [Abstract][Full Text] [Related]
48. Chikungunya virus adaptation to a mosquito vector correlates with only few point mutations in the viral envelope glycoprotein. Arias-Goeta C; Moutailler S; Mousson L; Zouache K; Thiberge JM; Caro V; Rougeon F; Failloux AB Infect Genet Evol; 2014 Jun; 24():116-26. PubMed ID: 24681263 [TBL] [Abstract][Full Text] [Related]
49. Structural basis of Chikungunya virus inhibition by monoclonal antibodies. Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569 [TBL] [Abstract][Full Text] [Related]
50. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220 [TBL] [Abstract][Full Text] [Related]
51. Development of a pseudotyped-lentiviral-vector-based neutralization assay for chikungunya virus infection. Kishishita N; Takeda N; Anuegoonpipat A; Anantapreecha S J Clin Microbiol; 2013 May; 51(5):1389-95. PubMed ID: 23408687 [TBL] [Abstract][Full Text] [Related]
52. Genetic characterization of chikungunya viruses isolated during the 2015-2017 outbreaks in different states of India, based on their E1 and E2 genes. Patil J; More A; Patil P; Jadhav S; Newase P; Agarwal M; Amdekar S; Raut CG; Parashar D; Cherian SS Arch Virol; 2018 Nov; 163(11):3135-3140. PubMed ID: 30073419 [TBL] [Abstract][Full Text] [Related]
53. Molecular investigations of chikungunya virus during outbreaks in Orissa, Eastern India in 2010. Das B; Sahu A; Das M; Patra A; Dwibedi B; Kar SK; Hazra RK Infect Genet Evol; 2012 Jul; 12(5):1094-101. PubMed ID: 22484761 [TBL] [Abstract][Full Text] [Related]
57. Chikungunya virus envelope-specific human monoclonal antibodies with broad neutralization potency. Warter L; Lee CY; Thiagarajan R; Grandadam M; Lebecque S; Lin RT; Bertin-Maghit S; Ng LF; Abastado JP; Desprès P; Wang CI; Nardin A J Immunol; 2011 Mar; 186(5):3258-64. PubMed ID: 21278338 [TBL] [Abstract][Full Text] [Related]
58. Following in the Footsteps of the Chikungunya Virus in Brazil: The First Autochthonous Cases in Amapá in 2014 and Its Emergence in Rio de Janeiro during 2016. de Souza TMA; Ribeiro ED; Corrêa VCE; Damasco PV; Santos CC; de Bruycker-Nogueira F; Chouin-Carneiro T; Faria NRDC; Nunes PCG; Heringer M; Lima MDRQ; Badolato-Corrêa J; Cipitelli MDC; Azeredo EL; Nogueira RMR; Dos Santos FB Viruses; 2018 Nov; 10(11):. PubMed ID: 30424530 [TBL] [Abstract][Full Text] [Related]
59. Genome-Wide Screening Uncovers the Significance of N-Sulfation of Heparan Sulfate as a Host Cell Factor for Chikungunya Virus Infection. Tanaka A; Tumkosit U; Nakamura S; Motooka D; Kishishita N; Priengprom T; Sa-Ngasang A; Kinoshita T; Takeda N; Maeda Y J Virol; 2017 Jul; 91(13):. PubMed ID: 28404855 [TBL] [Abstract][Full Text] [Related]
60. Emergence of a novel chikungunya virus strain bearing the E1:V80A substitution, out of the Mombasa, Kenya 2017-2018 outbreak. Eyase F; Langat S; Berry IM; Mulwa F; Nyunja A; Mutisya J; Owaka S; Limbaso S; Ofula V; Koka H; Koskei E; Lutomiah J; Jarman RG; Sang R PLoS One; 2020; 15(11):e0241754. PubMed ID: 33156857 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]